A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers
Status:
Completed
Trial end date:
2007-03-18
Target enrollment:
Participant gender:
Summary
GW679769 may affect liver enzymes that metabolize warfarin. This study is designed to test
the extent of the GW679769 affect on Warfarin levels in humans.